0
1
2
3
4
5
6
7
8
9

HealthTech 250 - The Most Promising Early-Stage Digital Health Ventures of 2023

The second annual edition of Galen Growth’s HealthTech 250 – The Most Promising Early Stage Digital Health Ventures in 2023, spans across all regions driving Digital Health innovation – North and South America, Asia Pacific, Europe, the Middle East and Africa. Covering the entire patient journey, they offer solutions from preventive measures to reimbursement, represented through 39 different Digital Health categories.

Funding trends remain pivotal, showcasing the industry's attractiveness and continued growth trajectory. As of October 2023, over $44 billion in venture capital funding has been deployed within the Digital Health sector. The HealthTech 250 ventures collectively raised a staggering $1.38 billion over the past 12 months, with the period from February to May witnessing an impressive $896 million raised in venture capital funding. April 2023 marked a significant milestone, with Orbital Therapeutics securing $270.0 million in a Series A funding round led by Arch Venture Partners, further amplifying the industry's appetite for transformative innovations.

The full analysis of the HealthTech 250 can be found on https://www.galengrowth.com/healthtech-250-the-most-promising-early-stage-digital-health-ventures-of-2023.
Last Updated: November 20, 2023

Ventures

ShowEntries
Showing 1 to 10 of 249 entries